From November 28 to 30, 2025, Professor Pier Paolo Piccaluga, an editorial board member (EBM) of Exploration of Targeted Anti-tumor Therapy (ETAT), successfully organized The 4th International Conference on Molecular Medicine and Clinical Diagnosis (MMCD 2025) in Xiamen, China. The conference brought together leading global experts and scholars to explore cutting-edge applications of molecular biology, genetics, medicine, and biotechnology in disease diagnosis, treatment, and prevention.

During the conference, Prof. Piccaluga introduced ETAT to attendees, highlighting the journal’s development and sharing insights from his role as both an EBM and a guest editor (GE). This initiative provided a valuable opportunity to enhance ETAT’s visibility and reputation within the global oncology community.

The Editorial Office expressed sincere gratitude to Prof. Piccaluga for his ongoing support and efforts in promoting the journal. Moving forward, ETAT will encourage more EBMs and GEs to engage with the academic community through international conferences, fostering deeper connections between the journal and the global oncology field.